MARYAM ESFAHANI ZAREH: Open Payments
NPI 1083254387 · GAITHERSBURG, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,643 in 64 payments from 19 companies in 2025. Trend: 2023 $1,499 · 2024 $2,141 · 2025 $1,643
Food & beverage: $1,643
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $239 |
| SCPHARMACEUTICALS INC. | 8 | $213 |
| Novartis Pharmaceuticals Corporation | 12 | $211 |
| Medtronic, Inc. | 1 | $149 |
| PFIZER INC. | 6 | $132 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $103 |
| E.R. Squibb & Sons, L.L.C. | 5 | $94 |
| Actelion Pharmaceuticals US, Inc. | 1 | $90 |
| Esperion Therapeutics, Inc. | 3 | $76 |
| Boston Scientific Corporation | 3 | $60 |
Products named: FUROSCIX, Wegovy, LEQVIO, AURORA EV-ICD MRI SURESCAN, ELIQUIS, JARDIANCE, UPTRAVI, VYNDAQEL.
Industry payments across MD — which companies pay providers there.
